158 related articles for article (PubMed ID: 31628681)
21. [Evaluation of the usefulness of endoglin level as a predictor of preeclampsia in pregnant women with hypertension].
Głuchowska M; Kowalska-Koprek U; Karowicz-Bilińska A
Ginekol Pol; 2013 Oct; 84(10):835-40. PubMed ID: 24273904
[TBL] [Abstract][Full Text] [Related]
22. Serum sFlt1:PlGF ratio, PlGF, and soluble endoglin levels in gestational proteinuria.
Ohkuchi A; Hirashima C; Matsubara S; Suzuki H; Takahashi K; Usui R; Suzuki M
Hypertens Pregnancy; 2009 Feb; 28(1):95-108. PubMed ID: 19165674
[TBL] [Abstract][Full Text] [Related]
23. Soluble endoglin as a second-trimester marker for preeclampsia.
Robinson CJ; Johnson DD
Am J Obstet Gynecol; 2007 Aug; 197(2):174.e1-5. PubMed ID: 17689640
[TBL] [Abstract][Full Text] [Related]
24. Maternal serum soluble endoglin at 30-33 weeks in the prediction of preeclampsia.
Lai J; Syngelaki A; Poon LC; Nucci M; Nicolaides KH
Fetal Diagn Ther; 2013; 33(3):149-55. PubMed ID: 23154616
[TBL] [Abstract][Full Text] [Related]
25. The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia.
Aggarwal PK; Chandel N; Jain V; Jha V
J Hum Hypertens; 2012 Apr; 26(4):236-41. PubMed ID: 21451568
[TBL] [Abstract][Full Text] [Related]
26. Differential Expression of Placental Growth Factor, Transforming Growth Factor-β and Soluble Endoglin in Peripheral Mononuclear Cells in Preeclampsia.
Ali Z; Ali Z; Khaliq S; Zaki S; Ahmad HU; Lone KP
J Coll Physicians Surg Pak; 2019 Mar; 29(3):235-239. PubMed ID: 30823949
[TBL] [Abstract][Full Text] [Related]
27. Angiogenic profile in the Finnish Genetics of Pre-Eclampsia Consortium (FINNPEC) cohort.
Jääskeläinen T; Heinonen S; Hämäläinen E; Pulkki K; Romppanen J; Laivuori H;
Pregnancy Hypertens; 2018 Oct; 14():252-259. PubMed ID: 29803331
[TBL] [Abstract][Full Text] [Related]
28. Circulating Angiogenic Factors and the Risk of Preeclampsia in Systemic Lupus Erythematosus Pregnancies.
Leaños-Miranda A; Campos-Galicia I; Berumen-Lechuga MG; Molina-Pérez CJ; García-Paleta Y; Isordia-Salas I; Ramírez-Valenzuela KL
J Rheumatol; 2015 Jul; 42(7):1141-9. PubMed ID: 25979720
[TBL] [Abstract][Full Text] [Related]
29. Effect on the production of soluble endoglin from human choriocarcinoma cells by preeclampsia sera.
Aoki Y; Yamamoto T; Fumihisa C; Nakamura A; Asanuma A; Suzuki M
Am J Reprod Immunol; 2012 May; 67(5):413-20. PubMed ID: 22040284
[TBL] [Abstract][Full Text] [Related]
30. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis.
Kleinrouweler CE; Wiegerinck MM; Ris-Stalpers C; Bossuyt PM; van der Post JA; von Dadelszen P; Mol BW; Pajkrt E;
BJOG; 2012 Jun; 119(7):778-87. PubMed ID: 22433027
[TBL] [Abstract][Full Text] [Related]
31. Peripheral arterial tonometry and angiogenic biomarkers in preeclampsia.
Kumer K; Premru-Sršen T; Fabjan-Vodušek V; Tul N; Fabjan T; Osredkar J
Hypertens Pregnancy; 2018 Nov; 37(4):197-203. PubMed ID: 30282501
[TBL] [Abstract][Full Text] [Related]
32. Effect of sildenafil citrate on circulating levels of sFlt-1 in preeclampsia.
Brownfoot FC; Tong S; Hannan NJ; Cannon P; Nguyen V; Kaitu'u-Lino TJ
Pregnancy Hypertens; 2018 Jul; 13():1-6. PubMed ID: 30177033
[TBL] [Abstract][Full Text] [Related]
33. The expression of serum sEGFR, sFlt-1, sEndoglin and PLGF in preeclampsia.
Cui L; Shu C; Liu Z; Tong W; Cui M; Wei C; Tang JJ; Liu X; Hu J; Jiang J; He J; Zhang DY; Ye F; Li Y
Pregnancy Hypertens; 2018 Jul; 13():127-132. PubMed ID: 30177039
[TBL] [Abstract][Full Text] [Related]
34. Association between endoglin/transforming growth factor beta receptors 1, 2 gene polymorphisms and the level of soluble endoglin with preeclampsia in Egyptian women.
ElMonier AA; El-Boghdady NA; Abdelaziz MA; Shaheen AA
Arch Biochem Biophys; 2019 Feb; 662():7-14. PubMed ID: 30496724
[TBL] [Abstract][Full Text] [Related]
35. [The correlation between cerebral MRI characteristics of posterior reversible encephalopathy syndrome and serum levels of PlGF, sEng in patients with pre-eclampsia].
Jiang KM; Zhong X; Tan Y; Liu GC; Mai H; Wu SX
Zhonghua Fu Chan Ke Za Zhi; 2016 Nov; 51(11):840-844. PubMed ID: 27916068
[No Abstract] [Full Text] [Related]
36. [Study on p38 mitogen activated protein kinase in vascular endothelial cells dysfunction in preeclampsia].
Luo X; Liu DD; Qi HB; Yao ZW
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):36-40. PubMed ID: 21429433
[TBL] [Abstract][Full Text] [Related]
37. Circulating Maternal Total Cell-Free DNA, Cell-Free Fetal DNA and Soluble Endoglin Levels in Preeclampsia: Predictors of Adverse Fetal Outcome? A Cohort Study.
AbdelHalim RM; Ramadan DI; Zeyada R; Nasr AS; Mandour IA
Mol Diagn Ther; 2016 Apr; 20(2):135-49. PubMed ID: 26790664
[TBL] [Abstract][Full Text] [Related]
38. Relationship of Liver X Receptors α and Endoglin Levels in Serum and Placenta with Preeclampsia.
Wang J; Dong X; Wu HY; Wu N; Zhang XJ; Wang X; Shang LX
PLoS One; 2016; 11(10):e0163742. PubMed ID: 27736929
[TBL] [Abstract][Full Text] [Related]
39. Diagnostic and prognostic significance of serum soluble endoglin levels in preeclampsia and eclampsia.
Sachan R; Patel ML; Dhiman S; Gupta P; Sachan P; Shyam R
Adv Biomed Res; 2016; 5():119. PubMed ID: 27563629
[TBL] [Abstract][Full Text] [Related]
40. Angiogenic factors for prediction of preeclampsia and intrauterine growth restriction onset in high-risk women: AngioPred study.
Raia-Barjat T; Prieux C; Gris JC; Chapelle C; Laporte S; Chauleur C
J Matern Fetal Neonatal Med; 2019 Jan; 32(2):248-257. PubMed ID: 28889770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
